
Esperion Therapeutics ESPR
Country |
|
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
208 M |
Market Cap[1] |
$ 661 M |
EBITDA (LTM) |
$ 60.4 M |
P/E (LTM) |
- |
P/S (LTM) |
1.639676 |
EPS (LTM) |
-0.11 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Revolution Medicines
RVMD
|
$ 177.96 | 0.22 % | $ 33.8 B | Nasdaq Global Select Market | ||
|
Rhythm Pharmaceuticals
RYTM
|
$ 86.17 | 0.6 % | $ 5.6 B | Nasdaq Global Market,SPB | ||
|
Prelude Therapeutics Incorporated
PRLD
|
$ 3.26 | 0.9 % | $ 251 M | Nasdaq Global Select Market | ||
|
Sana Biotechnology
SANA
|
$ 2.27 | 6.22 % | $ 575 M | Nasdaq Global Select Market | ||
|
Pulmatrix
PULM
|
$ 1.36 | 4.61 % | $ 4.97 B | Nasdaq Global Select Market | ||
|
Zoetis
ZTS
|
$ 79.38 | 1.22 % | $ 35.2 B | NYSE,SPB | ||
|
Ultragenyx Pharmaceutical
RARE
|
$ 14.54 | 1.81 % | $ 1.43 B | Nasdaq Global Select Market,SPB | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.96 | 2.62 % | $ 1.32 B | Nasdaq Capital Market | ||
|
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | ||
|
Zymeworks
ZYME
|
$ 25.03 | 0.16 % | $ 1.29 B | NYSE | ||
|
AC Immune SA
ACIU
|
$ 2.39 | 2.08 % | $ 241 M | Nasdaq Global Market | ||
|
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Adagene
ADAG
|
$ 2.06 | 4.8 % | $ 122 M | Nasdaq Global Market | ||
|
Adial Pharmaceuticals
ADIL
|
$ 3.49 | 11.15 % | $ 2.33 M | Nasdaq Capital Market | ||
|
ADC Therapeutics SA
ADCT
|
$ 1.4 | 0.34 % | $ 178 M | NYSE | ||
|
ADMA Biologics
ADMA
|
$ 10.68 | 3.77 % | $ 2.55 B | Nasdaq Global Market | ||
|
Assembly Biosciences
ASMB
|
$ 20.09 | 0.19 % | $ 225 M | Nasdaq Global Select Market,SPB | ||
|
Allogene Therapeutics
ALLO
|
$ 1.31 | 3.08 % | $ 289 M | Nasdaq Global Select Market,SPB | ||
|
Amgen
AMGN
|
$ 432.49 | 0.08 % | $ 233 B | Nasdaq Global Select Market,SPB | ||
|
Ardelyx
ARDX
|
$ 3.09 | 2.51 % | $ 745 M | Nasdaq Global Market | ||
|
Armata Pharmaceuticals
ARMP
|
$ 3.37 | 9.06 % | $ 122 M | NYSE American | ||
|
Artelo Biosciences
ARTL
|
$ 2.7 | 0.36 % | $ 511 K | Nasdaq Global Select Market | ||
|
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market | ||
|
Bicycle Therapeutics plc
BCYC
|
$ 3.46 | 2.56 % | $ 240 M | Nasdaq Global Select Market | ||
|
Catabasis Pharmaceuticals, Inc.
CATB
|
- | -6.97 % | $ 657 M | Nasdaq Global Market | ||
|
Beam Therapeutics
BEAM
|
$ 23.47 | 4.57 % | $ 2.32 B | Nasdaq Global Select Market | ||
|
China Biologic Products Holdings, Inc.
CBPO
|
- | 1.68 % | $ 4.65 B | Nasdaq Global Select Market | ||
|
Benitec Biopharma
BNTC
|
$ 8.11 | 2.05 % | $ 378 M | Nasdaq Capital Market | ||
|
BioNTech SE
BNTX
|
$ 87.71 | 1.74 % | $ 21.2 B | Nasdaq Global Select Market | ||
|
ANI Pharmaceuticals
ANIP
|
$ 72.29 | 0.01 % | $ 1.45 B | Nasdaq Global Market,SPB | ||
|
C4 Therapeutics
CCCC
|
$ 2.77 | 0.36 % | $ 230 M | Nasdaq Global Select Market | ||
|
Cerus Corporation
CERS
|
$ 2.18 | 0.66 % | $ 415 M | Nasdaq Global Market | ||
|
Certara
CERT
|
$ 9.37 | 0.26 % | $ 1.5 B | Nasdaq Global Select Market | ||
|
Flexion Therapeutics, Inc.
FLXN
|
- | - | $ 459 M | Nasdaq Global Market | ||
|
Coherus BioSciences
CHRS
|
$ 0.99 | 1.9 % | $ 116 M | Nasdaq Global Market | ||
|
Corcept Therapeutics Incorporated
CORT
|
$ 110.16 | 0.47 % | $ 11.4 B | Nasdaq Capital Market,SPB | ||
|
CorMedix
CRMD
|
$ 7.26 | 0.95 % | $ 523 K | Nasdaq Global Market | ||
|
CRISPR Therapeutics AG
CRSP
|
$ 49.25 | 2.59 % | $ 4.43 B | Nasdaq Global Market,SPB | ||
|
Greenwich LifeSciences
GLSI
|
$ 14.55 | 1.48 % | $ 197 M | Nasdaq Capital Market | ||
|
Champions Oncology
CSBR
|
$ 4.7 | 0.94 % | $ 65 M | Nasdaq Capital Market | ||
|
Heat Biologics, Inc.
HTBX
|
- | -5.76 % | $ 99.8 M | Nasdaq Capital Market | ||
|
Cue Biopharma
CUE
|
$ 16.71 | 0.38 % | $ 1.58 B | Nasdaq Capital Market,SPB | ||
|
Kindred Biosciences, Inc.
KIN
|
- | 0.11 % | $ 419 M | Nasdaq Global Select Market | ||
|
DBV Technologies S.A.
DBVT
|
$ 9.05 | 2.71 % | $ 1.26 B | Nasdaq Global Select Market | ||
|
Alterity Therapeutics Limited
ATHE
|
$ 2.62 | 8.64 % | $ 16.8 B | Nasdaq Capital Market | ||
|
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market | ||
|
Actinium Pharmaceuticals
ATNM
|
$ 1.13 | 6.6 % | $ 35.3 M | NYSE American | ||
|
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market | ||
|
DiaMedica Therapeutics
DMAC
|
$ 7.57 | 0.75 % | $ 356 M | Nasdaq Capital Market | ||
|
Aytu BioScience
AYTU
|
$ 1.98 | 1.0 % | $ 24.4 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.